Literature DB >> 28642173

Protein functional effector sncRNAs (pfeRNAs) in lung cancer.

Malcolm Brock1, Yuping Mei2.   

Abstract

PIWI-interacting RNA Likes (piR-Ls) were recently reported to regulate functions of their target phospho-Proteins (p-Proteins) in somatic lung cells. However, the mechanism underlying this functionality remains unclear. piR-Ls interact with their targets through direct binding but do not follow base-pairing rules, known to have important roles at levels of transcription, RNA processing and translation for small non-coding RNA (sncRNA). These observations imply a fundamentally different type of sncRNA with behavior that causes a molecular response in their target p-Proteins. Furthermore, the interaction of piR-Ls with their targets regulates the functional efficacy of target p-Proteins. In addition, except for writers (kinase) and erasers (phosphatase), the functional efficacy of p-Proteins on their readers still remains unknown. It is reasonable to consider the existence of protein functional effector sncRNAs (pfeRNAs), which were identified by deep sequencing the immunoprecipitation products of antibodies targeting phosphorylated residues in proteins, as well as by functional analysis. pfeRNAs harbor unique features in size distribution, 3' terminal modification, shared core sequences, and functional manner, and could be new players in lung physiological and pathological conditions.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lung cancer; pfeRNAs; piR-Ls

Mesh:

Substances:

Year:  2017        PMID: 28642173     DOI: 10.1016/j.canlet.2017.06.013

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  A TRIzol-based method for high recovery of plasma sncRNAs approximately 30 to 60 nucleotides.

Authors:  Kristen P Rodgers; Alicia Hulbert; Hamza Khan; Maria Shishikura; Shun Ishiyama; Malcolm V Brock; Yuping Mei
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

2.  Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition.

Authors:  Zhizhen Dong; Jianrong Chen; Xuli Yang; Wenjie Zheng; Li Wang; Miao Fang; Mengna Wu; Min Yao; Dengfu Yao
Journal:  Oncotarget       Date:  2018-01-09

3.  piRDisease v1.0: a manually curated database for piRNA associated diseases.

Authors:  Azhar Muhammad; Ramay Waheed; Nauman Ali Khan; Hong Jiang; Xiaoyuan Song
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

Review 4.  Epigenetic roles of PIWI proteins and piRNAs in lung cancer.

Authors:  Hadis Fathizadeh; Zatollah Asemi
Journal:  Cell Biosci       Date:  2019-12-21       Impact factor: 7.133

5.  A Cost-Effective and Non-Invasive pfeRNA-Based Test Differentiates Benign and Suspicious Pulmonary Nodules from Malignant Ones.

Authors:  Wei Liu; Yuyan Wang; Hongchan Huang; Nadege Fackche; Kristen Rodgers; Beverly Lee; Wasay Nizam; Hamza Khan; Zhihao Lu; Xiangqian Kong; Yanfei Li; Naixin Liang; Xin Zhao; Xin Jin; Haibo Liu; Charles Conover Talbot; Peng Huang; James R Eshleman; Qi Lai; Yi Zhang; Malcolm V Brock; Yuping Mei
Journal:  Noncoding RNA       Date:  2021-12-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.